NAV
₹220.5601
as of 13 Nov 2026
Expense Ratio
2.06%
AUM
₹8,023 Cr
Lumpsum returns (CAGR)
- 1Y
- +3.15%
- 3Y
- +9.30%
- 5Y
- +12.83%
- Since Inception
- +11.71%
SIP returns (XIRR)
- 1Y
- +9.85%
- 3Y
- +2.84%
- 5Y
- +10.46%
- Since Inception
- +13.20%
Returns calculated from 16 February 2004 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹15,06,475 today — ₹6,00,000 invested, 17.7% XIRR.
₹6,00,000
Invested
₹15,06,475
Value today
17.7%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹5,01,634 today (17.5% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹35,09,868.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹15,06,475 in this fund vs ₹15,30,132 in the benchmark — underperformance of ₹23,657.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹5,58,947 today (5.59×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.35
Sharpe Ratio
—
Alpha
—
Beta
-0.34
Sortino
13.48%
Std Dev
-16.66%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology18.60%
- Telecom - Services15.03%
- Electrical Equipment9.54%
- Minerals & Mining8.96%
- Construction5.25%
- Consumer Durables5.02%
- Auto Components4.61%
- Capital Markets4.04%
- Chemicals & Petrochemicals3.25%
- Power3.12%
- IT - Software2.42%
- Transport Services1.57%
Each sector links to the mutual funds most exposed to it.
Thinking about quant Mid Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Aurobindo Pharma Limited10.14%
- 2Lloyds Metals And Energy Limited8.96%
- 3Tata Communications Limited8.79%
- 4Indus Towers Limited6.24%
- 5Irb Infrastructure Developers Limited5.25%
- 6Lg Electronics India Limited5.02%
- 7Bharat Heavy Electricals Ltd4.81%
- 8Premier Energies Limited4.73%
- 9Sona Blw Precision Forgings Limited4.61%
- 10Nippon Life India Asset Management Ltd4.04%
What this fund does
quant Mid Cap Fund · Regular · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, with wider price swings than large-caps.
About This Fund
quant Mid Cap Fund · Regular · Growth is a Mid Cap mutual fund offered by quant Mutual Fund. The fund has been operational for over 22 years. It manages assets worth ₹8,023 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY MIDCAP 150 TRI. The current expense ratio is 2.06%.